News

As per the agreement, miRagen will provide Silence with specific miRNA sequences, which Silence will formulate with its proprietary DBTC delivery system to develop multiple candidate drugs. MiRagen

ICON will provide Shire with a range of services including site and country feasibility, ethics and regulatory submissions, clinical trial monitoring, project management, medical management and medical data

CVT-301 is an inhaled formulation of levodopa (L-dopa) for the rapid relief from motor fluctuations associated with Parkinson’s disease. In the trial, CVT-301 achieved sufficient plasma levels of

BEMA Buprenorphine is a transmucosal form of buprenorphine, a partial mu-opiate receptor agonist, which incorporates a bioerodible mucoadhesive (BEMA) technology. BEMA Buprenorphine is currently in phase III trials

The new test will be designed to enable early treatment before reactivation of the TB disease, as a follow up to those who test positive for latent TB.

According to Korea Food and Drug Administration (KFDA), Supect, a drug manufactured by Ilyang Pharmaceutical has been approved to treat leukemia in those resistant to currently available anti-leukemia

The new system is said to facilitate the handling of liquid-based cytology and other types of liquid samples that are processed by clinical laboratories across the globe. According

Strides Arcolab is also securing investment bank Jefferies’ advice on divestment of softgel and anti-retro viral (ARV) drug manufacturing, timesofindia.indiatimes.com reported. Strides Arcolab plans to lay more emphasis

The manufacturing units including Southwest Synthetic Pharma Company, Intec Product, Suzhoudawn Ray’s Pharma and Hisoanchuannan Pharma Company will be inspected by the Indian officials. The cancellation of many